Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Dec;54(12):1683-7.

Treatment and prevention of herpes labialis

Wim Opstelten  1 , Arie Knuistingh Neven, Just Eekhof
Affiliations
Review

Treatment and prevention of herpes labialis

Wim Opstelten et al. Can Fam Physician. 2008 Dec.

Abstract
in English, French

Objective: To review the evidence regarding the treatment and prevention of herpes labialis.

Quality of evidence: The evidence relating to treatment and prevention of herpes labialis is derived from randomized controlled trials (level I evidence).

Main message: Treatment with an indifferent cream (zinc oxide or zinc sulfate), an anesthetic cream, or an antiviral cream has a small favourable effect on the duration of symptoms, if applied promptly. This is also the case with oral antiviral medication. If antiviral medicine (cream or oral) is started before exposure to the triggering factor (sunlight), it will provide some protection. Research on sunscreens has shown mixed results: some protection has been reported under experimental conditions that could not be replicated under natural conditions. In the long term, the number of relapses of herpes labialis can be limited with oral antiviral medication.

Conclusion: Only prompt topical or oral therapy will alleviate symptoms of herpes labialis. Both topical and oral treatment can contribute to the prevention of herpes labialis.

OBJECTIF: Revoir les données concernant le traitement et la prévention de l’herpès labial.

QUALITÉ DES PREUVES: Les preuves concernant le traitement et la prévention de l’herpès labial proviennent d’essais cliniques randomisés (preuves de niveau I).

PRINCIPAL MESSAGE: Le traitement avec une crème non spécifique (oxyde ou sulfate de zinc), anesthésiante ou antivirale a un effet légèrement favorable sur la durée des symptômes à condition que la crème soit appliquée précocement. On obtient le même effet avec une médication antivirale orale. Si le traitement antiviral (en crème ou per os) est institué avant l’exposition au facteur déclenchant (lumière solaire), il conférera une certaine protection. La recherche sur les écrans solaires a donné des résultats contradictoires: dans des conditions expérimentales, on a rapporté une certaine protection mais cela n’a pu être confirmé dans des conditions naturelles. À long terme, le nombre de récidives de l’herpès labial peut être réduit par les antiviraux oraux.

CONCLUSION: Seuls un traitement topique ou une médication orale précoces peuvent soulager les symptômes de l’herpès labial. Les traitements topiques ou oraux peuvent contribuer à la prévention de l’herpès labial.

PubMed Disclaimer

References

    1. Van der Linden MW, Westert GP, De Bakker DH, Schellevis FG. Second national study into diseases and actions in general practice. Utrecht, Bilthoven: Netherlands Institute for Health Services Research (NIVEL), National Institute of Public Health and the Environment (RIVM); 2004. [Dutch]
    1. Embil JA, Stephens RG, Manuel FR. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J. 1975;113(7):627–30. - PMC - PubMed
    1. Sparano JA, Sarta C. Infection prophylaxis and antiretroviral therapy in patients with HIV infection and malignancy. Curr Opin Oncol. 1996;8(5):392–9. - PubMed
    1. Scoular A, Norrie J, Gillespie G, Mir N, Carman WF. Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ. 2002;324(7350):1366–7. - PMC - PubMed
    1. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 1987;316(23):1444–9. - PubMed

MeSH terms

Substances